ESR1 and triple-negative breast carcinoma: Triple-negative breast cancers (TNBC) are an aggressive subtype, characterized by a lack of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression.